scholarly journals BI28: Immune reconstitution syndrome following discontinuation of long‐term azathioprine for ulcerative colitis

2021 ◽  
Vol 185 (S1) ◽  
pp. 155-155
2005 ◽  
Vol 41 (10) ◽  
pp. 1483-1497 ◽  
Author(s):  
P. Phillips ◽  
S. Bonner ◽  
N. Gataric ◽  
T. Bai ◽  
P. Wilcox ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A624-A624 ◽  
Author(s):  
J ARTS ◽  
M ZEEGERS ◽  
G DHAENS ◽  
G VANASSCHE ◽  
M HIELE ◽  
...  

2015 ◽  
Vol 17 (8) ◽  
pp. 47-50
Author(s):  
A.I. Parfenov ◽  
◽  
O.V. Knyazev ◽  
I.N. Ruchkina ◽  
◽  
...  

2020 ◽  
Author(s):  
Emma Culver ◽  
Helen K. Bungay ◽  
Margaret Betts ◽  
Colm Forde ◽  
Otto Buchel ◽  
...  

Author(s):  
Sara Santos ◽  
Verónica Gamelas ◽  
Rita Saraiva ◽  
Guilherme Simões ◽  
Joana Saiote ◽  
...  

Tofacitinib has emerged as a new option for ulcerative colitis. Its rapid absorption, metabolism, and clinical improvement make it an interesting option for rescue therapy in acute severe ulcerative colitis (ASUC), a situation with limited therapeutic options in patients with a long-term disease course and multiple drug failure. The management of ASUC in this setting becomes challenging, underlying the need for new drugs and data on their efficacy and safety. We describe 2 cases of acute episodes in which tofacitinib was used as a rescue therapy.


Sign in / Sign up

Export Citation Format

Share Document